Larvol Delta - OS-Therapies-Announces-Last-Patient-Enrolled-in-OST504-previously-ADXS504-Phase-1b-Prostate-Cancer-Clinical-Trial-Completes-Last-Visit

OST-504 - OS Therapies

https://www.newsfilecorp.com/release/266139/OS-Therapies-Announces-Last-Patient-Enrolled-in-OST504-previously-ADXS504-Phase-1b-Prostate-Cancer-Clinical-Trial-Completes-Last-Visit

Sep 12, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next